Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.69EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
ER.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.640EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.1.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.43.6 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBF.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.27EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.43.9 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XUEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.3 (Omicron)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.16.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.372EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.425EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.144EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.288EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.249EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.378EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.97EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.439EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.408EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.256EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Q.7 (Alpha)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.460EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.262EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBUEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.351.5 (Beta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FZ.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.9.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBC.1.6.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.4.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FQ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JB.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.3.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FZ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DV.7.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.30.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.68EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CD.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.122.3 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.53 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.599EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used